Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05361746 · ClinicalTrials.gov registry record · NA
Scotchbond Universal Plus Compared to Scotchbond Universal With Filtek Universal Restorative to Restore Class V NCCLs
A NA study of Class V Non-carious Cervical Dental Lesions, sponsored by Solventum US.
- Active
- Registry status
- NA
- Development phase
- 38
- Enrollment target
- 1
- Study location
NCT05361746: Active NA study of Class V Non-carious Cervical Dental Lesions, sponsored by Solventum US.
NCT05361746 is a NA study of Class V Non-carious Cervical Dental Lesions that is active but no longer recruiting, run by Solventum US. The registered enrollment target is 38 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05361746, a NA study of Class V Non-carious Cervical Dental Lesions, is active but no longer recruiting, sponsored by Solventum US.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective, controlled, within-subject, randomized, single-center study comparing Scotchbond Universal Plus and Scotchbond Universal adhesives when used with Filtek restorative. The study will enroll a minimum of 46 Subjects with Class-V non-carious cervical lesion (NCCL) on a minimum of two teeth.
Primary Outcome
The percentage of restorations with partial or complete loss of the restorative materials.
Conditions Studied
Interventions
- DEVICE Scotchbond Universal Plus Adhesive
- DEVICE Scotchbond Universal Adhesive
Study Locations (1)
Louisiana
- Louisiana State University HSC-Health, School of Dentistry - New Orleans
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2022-08-18 |
| Est. Completion | 2025-07-30 |
| Phase | NA |
What the registry record for NCT05361746 still lists
NCT05361746 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 38 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Class V Non-carious Cervical Dental Lesions appearing as the primary indexed condition, and to 2 interventions - of which Scotchbond Universal Plus Adhesive is the first listed.
NCT05361746 reports a single indexed study location in Louisiana.
Frequently Asked Questions
What is clinical trial NCT05361746 about?
NCT05361746 is a clinical study titled "Scotchbond Universal Plus Compared to Scotchbond Universal With Filtek Universal Restorative to Restore Class V NCCLs". This is a prospective, controlled, within-subject, randomized, single-center study comparing Scotchbond Universal Plus and Scotchbond Universal adhesives when used with Filtek restorative. The study will enroll a minimum of 46 Subjects with Class-V non-carious cervical lesion (NCCL) on a minimum of ...
What is the current status of trial NCT05361746?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 38 participants. The study started on 2022-08-18. Estimated completion is 2025-07-30.
What conditions does trial NCT05361746 study?
This clinical trial studies the following conditions: Class V Non-carious Cervical Dental Lesions.
What interventions are being tested in trial NCT05361746?
The interventions under investigation include: Scotchbond Universal Plus Adhesive (DEVICE), Scotchbond Universal Adhesive (DEVICE).
Who is sponsoring clinical trial NCT05361746?
This trial is sponsored by Solventum US, which has 41 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05361746 being conducted?
This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05361746's enrollment target sits among peer trials
38 1538th of 2000 higher than 461 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI